Trevo NXT ProVue Retriever

FDA 510(k) K200117 · Stryker

Substantially Equivalent

510(k) numberK200117

Submission

Device name
Trevo NXT ProVue Retriever
Applicant
Stryker
Fremont, CA, US
Received
January 21, 2020
Decision date
February 7, 2020
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
POL – Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5600
Specialty
Neurology

A neurovascular mechanical thrombectomy device for acute ischemic stroke treatment is a prescription device used in the treatment of acute ischemic stroke to improve clinical outcomes. The device is delivered into the neurovasculature with an endovascular approach, mechanically removes thrombus from the body, and restores blood flow in the neurovasculature.

Other 510(k)s with product code POL

510(k)DeviceApplicantDecision
K242676pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy DevicePOL · Special Phenox Limited02/28/2025SE
K231539pRESET LITE Thrombectomy DevicePOL · Traditional Phenox Limited10/21/2023SE
K223305Trevo NXT ProVue RetrieverPOL · Traditional Stryker Neurovascular03/29/2023SE
K222848pRESET Thrombectomy DevicePOL · Traditional Phenox Limited01/20/2023SE
K210502Trevo NXT ProVue RetrieverPOL · Traditional Stryker Neurovascular08/27/2021SE
K203358Solitaire X Revascularization DevicePOL · Traditional Micro Therapeutics, Inc. d/b/a ev3 Neurovascular03/01/2021SE
K203219Trevo XP ProVue Retriever and Trevo NXT™ ProVue RetrieverPOL · Traditional Stryker Neurovascular12/29/2020SE
K193576Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device…POL · Traditional Micro Therapeutics, Inc. d/b/a ev3 Neurovascular11/20/2020SE
K192207Trevo NXT ProVue RetrieverPOL · Traditional Stryker11/22/2019SE
K190779Trevo XP ProVue RetrieverPOL · Traditional Stryker06/25/2019SE

More from Stryker

510(k)DeviceDecision
K261481Pangea Femur Reconstruction SystemHSB · Traditional 06/29/2026SE
K253640T2 Alpha Femur Retrograde Nailing System; Pangea Femur Reconstruction SystemHSB · Traditional 02/03/2026SE
K253202Hoffmann LRF SystemKTT · Traditional 12/19/2025SE
K251400T2 Alpha Humerus Nailing System; IMN Screws System; T2 Nailing SystemHSB · Traditional 08/20/2025SE
K250163T2 Alpha Femur Retrograde Nailing SystemHSB · Traditional 08/13/2025SE
K242445Pangea Platform; Pangea Femur Plating System; Pangea Humerus Plating System; Pangea…HRS · Traditional 10/06/2024SE
K233919VariAx 2 Distal Radius SystemHRS · Traditional 03/25/2024SE
K233741Hoffmann LRF SystemKTT · Special 12/21/2023SE
K230045HipCheckQIH · Traditional 09/29/2023SE
K2318541788 4K Camera System with Advanced Imaging Modality; L12 LED Light Source with AIMOWN · Traditional 09/20/2023SE

Questions and answers

When was Trevo NXT ProVue Retriever cleared by the FDA?

Trevo NXT ProVue Retriever (K200117) received a 510(k) decision of Substantially Equivalent on February 7, 2020, 17 days after the submission was received.

What is the product code of K200117?

The FDA product code is POL – Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment, a Class II (moderate risk) device regulated under 21 CFR 882.5600.